Hypera S.A.
HYPE3
Ранг среди акций
#4245
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
Цена акции
$5.33
Рыночная капитализация
$3.75B
Изменение (1 день)
2.16%
Изменение (1 год)
25.26%
Страна
BR
Торговля Hypera S.A. (HYPE3)
Категория
Healthcare
Коэффициент P/S для Hypera S.A. (HYPE3)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Hypera S.A., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Hypera S.A. с 2026 по 2026
Коэффициент P/S в конце каждого года
| Год | P/S | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
Коэффициент P/S для аналогичных компаний или конкурентов
| Компания | P/S | Разница P/S | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | - |
IN
|
